While almost all antibodies showed a slight non-significantly higher tau load in AD versus AD-LB cases, AT100 detected a slightly non-significant higher tau load in AD-LB compared to AD cases (Fig. 6). This evidence concerns the gene MAPT and Alzheimer disease.